Articles producció científica> Medicina i Cirurgia

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

  • Identification data

    Identifier: imarina:9226941
    Authors:
    Suarez-Garcia, InesAlejos, BelenPerez-Elias, Maria-JesusIribarren, Jose-AntonioHernando, AsuncionRamirez, MargaritaTasias, MariaPascual, MarioJarrin, InmaHernando, VictoriaCoRIS Cohort
    Abstract:
    Background To estimate the prevalence and severity of menopausal symptoms and anxiety/depression and to assess the differences according to menopausal status among women living with HIV aged 45-60 years from the cohort of Spanish HIV/AIDS Research Network (CoRIS). Methods Women were interviewed by phone between September 2017 and December 2018 to determine whether they had experienced menopausal symptoms and anxiety/depression. The Menopause Rating Scale was used to evaluate the prevalence and severity of symptoms related to menopause in three subscales: somatic, psychologic and urogenital; and the 4-item Patient Health Questionnaire was used for anxiety/depression. Logistic regression models were used to estimate odds ratios (ORs) of association between menopausal status, and other potential risk factors, the presence and severity of somatic, psychological and urogenital symptoms and of anxiety/depression. Results Of 251 women included, 137 (54.6%) were post-, 70 (27.9%) peri- and 44 (17.5%) pre-menopausal, respectively. Median age of onset menopause was 48 years (IQR 45-50). The proportions of pre-, peri- and post-menopausal women who had experienced any menopausal symptoms were 45.5%, 60.0% and 66.4%, respectively. Both peri- and post-menopause were associated with a higher likelihood of having somatic symptoms (aOR 3.01; 95% CI 1.38-6.55 and 2.63; 1.44-4.81, respectively), while post-menopause increased the likelihood of having psychological (2.16; 1.13-4.14) and urogenital symptoms (2.54; 1.42-4.85). By other hand, post-menopausal women had a statistically significant five-fold increase in the likelihood of presenting severe urogenital symptoms than pre-menopausal women (4.90; 1.74-13.84). No significant differences by menopausal status were found for anxiety/depre
  • Others:

    Author, as appears in the article.: Suarez-Garcia, Ines; Alejos, Belen; Perez-Elias, Maria-Jesus; Iribarren, Jose-Antonio; Hernando, Asuncion; Ramirez, Margarita; Tasias, Maria; Pascual, Mario; Jarrin, Inma; Hernando, Victoria;CoRIS Cohort
    Department: Medicina i Cirurgia
    URV's Author/s: PERAIRE FORNER, JOSÉ JOAQUIN
    Keywords: Vasomotor symptoms Transition Symptoms Social support Perimenopausal Onset Menopause Infection Hiv infection Health Depression Association Anxiety
    Abstract: Background To estimate the prevalence and severity of menopausal symptoms and anxiety/depression and to assess the differences according to menopausal status among women living with HIV aged 45-60 years from the cohort of Spanish HIV/AIDS Research Network (CoRIS). Methods Women were interviewed by phone between September 2017 and December 2018 to determine whether they had experienced menopausal symptoms and anxiety/depression. The Menopause Rating Scale was used to evaluate the prevalence and severity of symptoms related to menopause in three subscales: somatic, psychologic and urogenital; and the 4-item Patient Health Questionnaire was used for anxiety/depression. Logistic regression models were used to estimate odds ratios (ORs) of association between menopausal status, and other potential risk factors, the presence and severity of somatic, psychological and urogenital symptoms and of anxiety/depression. Results Of 251 women included, 137 (54.6%) were post-, 70 (27.9%) peri- and 44 (17.5%) pre-menopausal, respectively. Median age of onset menopause was 48 years (IQR 45-50). The proportions of pre-, peri- and post-menopausal women who had experienced any menopausal symptoms were 45.5%, 60.0% and 66.4%, respectively. Both peri- and post-menopause were associated with a higher likelihood of having somatic symptoms (aOR 3.01; 95% CI 1.38-6.55 and 2.63; 1.44-4.81, respectively), while post-menopause increased the likelihood of having psychological (2.16; 1.13-4.14) and urogenital symptoms (2.54; 1.42-4.85). By other hand, post-menopausal women had a statistically significant five-fold increase in the likelihood of presenting severe urogenital symptoms than pre-menopausal women (4.90; 1.74-13.84). No significant differences by menopausal status were found for anxiety/depression. Joint/muscle problems, exhaustion and sleeping disorders were the most commonly reported symptoms among all women. Differences in the prevalences of vaginal dryness (p = 0.002), joint/muscle complaints (p = 0.032), and sweating/flush (p = 0.032) were found among the three groups. Conclusions Women living with HIV experienced a wide variety of menopausal symptoms, some of them initiated before women had any menstrual irregularity. We found a higher likelihood of somatic symptoms in peri- and post-menopausal women, while a higher likelihood of psychological and urogenital symptoms was found in post-menopausal women. Most somatic symptoms were of low or moderate severity, probably due to the good clinical and immunological situation of these women.
    Thematic Areas: Sociologia i política Saúde coletiva Reproductive medicine Public, environmental & occupational health Psicología Obstetrics and gynecology Obstetrics & gynecology Medicine (miscellaneous) Medicina iii Medicina ii Medicina i Interdisciplinar General o multidisciplinar General medicine Enfermagem Educação física Educação Economia Direito Ciencias sociales Ciências biológicas ii Biotecnología Antropologia / arqueologia
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    Author's mail: joaquim.peraire@urv.cat
    Author identifier: 0000-0001-7808-5479
    Record's date: 2021-10-10
    Papper version: info:eu-repo/semantics/publishedVersion
    Link to the original source: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.25.2000236
    Papper original source: Bmc Womens Health. 21 (1):
    APA: Suarez-Garcia, Ines; Alejos, Belen; Perez-Elias, Maria-Jesus; Iribarren, Jose-Antonio; Hernando, Asuncion; Ramirez, Margarita; Tasias, Maria; Pascual, (2021). How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort. Bmc Womens Health, 21(1), -. DOI: 10.1186/s12905-021-01370-w
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Article's DOI: 10.1186/s12905-021-01370-w
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2021
    Publication Type: Journal Publications
  • Keywords:

    Medicine (Miscellaneous),Obstetrics & Gynecology,Obstetrics and Gynecology,Public, Environmental & Occupational Health,Reproductive Medicine
    Vasomotor symptoms
    Transition
    Symptoms
    Social support
    Perimenopausal
    Onset
    Menopause
    Infection
    Hiv infection
    Health
    Depression
    Association
    Anxiety
    Sociologia i política
    Saúde coletiva
    Reproductive medicine
    Public, environmental & occupational health
    Psicología
    Obstetrics and gynecology
    Obstetrics & gynecology
    Medicine (miscellaneous)
    Medicina iii
    Medicina ii
    Medicina i
    Interdisciplinar
    General o multidisciplinar
    General medicine
    Enfermagem
    Educação física
    Educação
    Economia
    Direito
    Ciencias sociales
    Ciências biológicas ii
    Biotecnología
    Antropologia / arqueologia
  • Documents:

  • Cerca a google

    Search to google scholar